Canada Court Rejects Generic Drug makers Bid to market Generic Viagra

19 June, 2009

The Federal Court of Canada rejected generic drug maker Novapharm Ltd's bid to be allowed to market a generic version of Pfizer Inc's erectile dysfunction drug Viagra (Sildenafil Citrate).

The decision has been taken keeping in mind Pfizer's Canadian patent. The court said Novapharm should not be allowed to introduce a generic version until Pfizer's Canadian patent expires in 2014. The court rejected Novapharm's allegation that the patent is invalid. Novapharm is part of Teva Pharmaceutical Industries Ltd.